Page 31 - நாஸ்டாக் முதல் வடக்கு ப்ரிமியர் வளர்ச்சி சந்தை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Isofol receives recommendation from iDSMB to complete the global Phase III AGENT study for market registration as planned with 440 patients

Isofol receives recommendation from iDSMB to complete the global Phase III AGENT study for market registration as planned with 440 patients
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Vastra gotalands lanUlf jungneliusMerck kgaMerck kgaaNasdaq first north premier growth marketData safetyMonitoring boardNew drug applicationChief executiveChief medicalIsofol medicalNasdaq first north premier growthCertified adviserமெர்க் க்கநாஸ்டாக் முதல் வடக்கு ப்ரிமியர் வளர்ச்சி சந்தைதகவல்கள் பாதுகாப்பு

Auriant Mining AB : (publ ) will publish the Annual Report on 20 April 2021

www.mangold.se. Cautionary Statement: Statements and assumptions made in this report with respect to Auriant Mining AB’s (“AUR”) current plans, estimates, strategies and beliefs, and other statements that are not historical facts, are forward-looking statements about the future performance of AUR. Forward-looking statements include, but are not limited to, those using words such as may , might , seeks , expects , anticipates , estimates , believes , projects , plans , strategy , forecast and similar expressions. These statements reflect management s expectations and assumptions in light of currently available information. They are subject to a number of risks and uncertainties, including, but not limited to, (i) changes in the economic, regulatory and political environments in the countries where AUR operates; (ii) changes relating to the geological information available in respect of the various projects undertaken; (iii) AUR’s continued ability to secure enough

United statesNew zealandHong kongRussia generalSouth africaArkhangel skaya oblastDanilo langeEu pressAnnual reportAuriant miningNasdaq first north premier growth marketCertified adviserAustralia japanUnited states securities actAuriant mining ab publ stock exchangePress release

Implantica makes headway in Italy and Spain with its medical device RefluxStop

Implantica makes headway in Italy and Spain with its medical device RefluxStop STOCKHOLM, March 15, 2021 /PRNewswire/ Implantica AG (publ) today announces that the company will start commercializing RefluxStop on a reimbursed basis in Italy and Spain based on local/regional hospital agreements. Implantica will now focus on providing RefluxStop to the leading anti-reflux surgeons and centers in Italy and Spain. Surgical training will commence initially via webinar with representatives from Germany and Switzerland until Covid-19 subsides. We look forward to continue to develop the KOL (key opinion leader) networks and train surgeons in Italy and Spain and to sell RefluxStop on a reimbursed basis based on individual hospital /regional agreements said Peter Forsell, CEO of Implantica. At this stage we will mainly focus on the larger anti-reflux centers, and we will extend our registry study also to these countries to collect data for RefluxStop.

Nicole pehrssonPeter forsellNasdaq first north premier growth marketCertified adviserMedi calநாஸ்டாக் முதல் வடக்கு ப்ரிமியர் வளர்ச்சி சந்தைமேதி கலோரி

Implantica makes headway in Italy and Spain with its medical device RefluxStop™

Implantica makes headway in Italy and Spain with its medical device RefluxStop™
yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.

Implantica agNasdaq first north premier growth marketRegional agreementsநாஸ்டாக் முதல் வடக்கு ப்ரிமியர் வளர்ச்சி சந்தை

Terranet: The last day of trading with the warrants of series (2020:2) TO2 B in TerraNet Holding AB is today, March 12, 2021

(1) Today, March 12, 2021, is the last day of trading with the warrants of series TO2 B in TerraNet Holding AB ( TerraNet or the Company ). The subscription period for the warrants of series TO2 B runs until March 19, 2021. Each warrant of series TO2 B gives the owner the right to subscribe for one (1) new B-share in the Company. The exercise price for the warrants of series TO2 B is SEK 0.80 per B-share. Please note that trading and exercise of warrants of series TO2 B that are nominee registered must be conducted in accordance with instructions from each respective nominee. Owners of warrants of series TO2 B should contact their nominee for further instructions.

Olof johannessonTerranet holdingSwedish companies registration officeTerranet holding abSwedish companies registrationMangold fondkommissionNasdaq first north premier growth marketஸ்விட்ச் நிறுவனங்கள் பதிவு அலுவலகம்ஸ்விட்ச் நிறுவனங்கள் பதிவுநாஸ்டாக் முதல் வடக்கு ப்ரிமியர் வளர்ச்சி சந்தை